Nobuo Ohta
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Nobuo Ohta has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Masaru Aoyagi
Organic Materials Diagnosis Group, Research Institute for Sustainable Chemistry, National Institute of Advanced Industrial Science and Technology (AIST), 3-11-32 Kagamiyama, Higashihiroshima 739-0046, Hiroshima, Japan
3 shared publications Shigeru Fukase
Fukase Ear, Nose, Throat and Allergy Clinic
2 shared publicationsToshinori Kubota
Department of Otolaryngology, Head and Neck Surgery, Yamagata University Faculty of Medicine, 2-2-2 Iida-nishi, Yamagata 990-9585, Japan
2 shared publications- Yusuke Suzuki
Department of Respiratory Medicine, Kitasato University Kitasato Institute Hospital, Tokyo, Japan
2 shared publications Akihiro Ishida
Department of Otolaryngology, Head and Neck Surgery, Yamagata University Faculty of Medicine, 2-2-2 Iida-nishi, Yamagata 990-9585, Japan
1 shared publication- Kimihiro Okubo
Department of Otorhinolaryngology, Nippon Medical School, Tokyo, Japan
1 shared publication
Latest Publications
- Open Access
- 1 January 2020
- Published by Tottori University Faculty of Medicine in Yonago Acta Medica
- Vol. 63 (1) , 88-91
Brain Abscess as a Rare Complication of Primary Extranodal Nasal-type Natural Killer/T-cell Lymphoma
We present the case of a 58-year-old Japanese woman with a natural killer T (NK/T)-cell lymphoma complicated by brain abscess. NK/T-cell lymphomas represent a rare type of lymphoma derived from either activated NK cells or, rarely, cytotoxic T cells. They are aggressive Epstein-Barr virus (EBV)-associated lymphomas that involve mainly the nasal cavity. Brain abscess associated with primary extranodal nasal-type NK/T-cell lymphoma is extremely uncommon: to our knowledge, this is the first reported case of this lymphoma with brain abscess as the initial clinical manifestation. Endoscopic surgery was performed for definitive diagnosis under intraoperative navigation system. Chemotherapy followed by radiotherapy was performed and was effective: 72 months later the tumor has not recurred. Recommendations of endoscopic management for diagnosis and treatment of this rare neoplasm are discussed.
- 1 January 2020
- Published by Tottori University Faculty of Medicine in Yonago Acta Medica
- Vol. 63 (1) , 88-91
Open AccessBrain Abscess as a Rare Complication of Primary Extranodal Nasal-type Natural Killer/T-cell Lymphoma
We present the case of a 58-year-old Japanese woman with a natural killer T (NK/T)-cell lymphoma complicated by brain abscess. NK/T-cell lymphomas represent a rare type of lymphoma derived from either activated NK cells or, rarely, cytotoxic T cells. They are aggressive Epstein-Barr virus (EBV)-associated lymphomas that involve mainly the nasal cavity. Brain abscess associated with primary extranodal nasal-type NK/T-cell lymphoma is extremely uncommon: to our knowledge, this is the first reported case of this lymphoma with brain abscess as the initial clinical manifestation. Endoscopic surgery was performed for definitive diagnosis under intraoperative navigation system. Chemotherapy followed by radiotherapy was performed and was effective: 72 months later the tumor has not recurred. Recommendations of endoscopic management for diagnosis and treatment of this rare neoplasm are discussed.
- Open Access
- 29 September 2012
- Published by Wiley in Case Reports in Otolaryngology
- Vol. 2012, 1-4
A Case of Sublingual Dermoid Cyst: Extending the Limits of the Oral Approach
We present the case of a dermoid cyst with an oral and a submental component in a 21-year-old Japanese woman who presented with complaints of a mass in the oral cavity and difficulty in chewing and swallowing solid foods for about 2 years. MRI shows a 55 × 65 mm well-circumscribed cystic mass extending from the sublingual area to the mylohyoid muscle. Under general anesthesia and with nasotracheal intubation, the patient underwent surgical removal of the mass. Although the cyst was large and extending mylohyoid muscle, intraoral midline incision was performed through the mucosa overlying the swelling and the cyst was separated from the surrounding tissues with appropriate traction and countertraction and successfully removed without extraoral incision. Oral approach in surgical enucleation is useful procedure to avoid cosmetic problems in large and extending mylohyoid muscle cyst.
- 29 September 2012
- Published by Wiley in Case Reports in Otolaryngology
- Vol. 2012, 1-4
Open AccessA Case of Sublingual Dermoid Cyst: Extending the Limits of the Oral Approach
We present the case of a dermoid cyst with an oral and a submental component in a 21-year-old Japanese woman who presented with complaints of a mass in the oral cavity and difficulty in chewing and swallowing solid foods for about 2 years. MRI shows a 55 × 65 mm well-circumscribed cystic mass extending from the sublingual area to the mylohyoid muscle. Under general anesthesia and with nasotracheal intubation, the patient underwent surgical removal of the mass. Although the cyst was large and extending mylohyoid muscle, intraoral midline incision was performed through the mucosa overlying the swelling and the cyst was separated from the surrounding tissues with appropriate traction and countertraction and successfully removed without extraoral incision. Oral approach in surgical enucleation is useful procedure to avoid cosmetic problems in large and extending mylohyoid muscle cyst.
- 1 January 2011
- Published by The Society of Practical Otolaryngology in Practica oto-rhino-laryngologica. Suppl.
- Vol. 130, 44-48
Prophylactic Effect and QOL in Cases of Japanese Cedar Pollinosis
In a pollen-season study of the clinical prophylactic effect in those with Japanese cedar allergy, we found that symptoms were less severe and quality of life (QOL) higher in those treated before rather than after pollen season started. These results indicate that prophylacsis is effective in treating Japanese cedar pollinosis.
- 1 January 2011
- Published by The Society of Practical Otolaryngology in Practica oto-rhino-laryngologica. Suppl.
- Vol. 130, 44-48
Prophylactic Effect and QOL in Cases of Japanese Cedar Pollinosis
In a pollen-season study of the clinical prophylactic effect in those with Japanese cedar allergy, we found that symptoms were less severe and quality of life (QOL) higher in those treated before rather than after pollen season started. These results indicate that prophylacsis is effective in treating Japanese cedar pollinosis.
- 1 June 2010
- Published by Wiley in Otolaryngology–Head and Neck Surgery
- Vol. 142 (6) , 863-866
Treatment of auricular hematoma by OK‐432
Objectives: Intralesional injection therapy with OK‐432 was developed as a therapy for operatively difficult lymphangioma (cystic hygroma) and is currently becoming a first‐choice treatment for this disease. The aim of this article was to evaluate the outcome and complications of the treatment of patients with auricular hematoma by OK‐432 therapy.Study Design: Case series with planned data collection.Setting: Yamagata University School of Medicine.Subjects and Methods: We tried this therapy in 21 patients with auricular hematoma between January 2001 and February 2009. We injected OK‐432 solution into the lesion with a 27‐gauge needle to prevent the leak of the agent out of the hematoma. We performed this treatment on an outpatient basis without hospitalization.Results: Disappearance or marked reduction of the lesion were observed in all patients who had this therapy, and local scarring and deformity of the auricle did not occur in any patients. As for side effects, local pain at the injection site and fever (37°C‐38°C) were observed in a few of the patients who had this therapy, but such problems resolved within a few days.Conclusion: These results may allow us to speculate that intralesional injection therapy with OK‐432 is simple, easy, safe, and effective and can be used as a substitute for surgery in the treatment of auricular hematoma.
- 1 June 2010
- Published by Wiley in Otolaryngology–Head and Neck Surgery
- Vol. 142 (6) , 863-866
Treatment of auricular hematoma by OK‐432
Objectives: Intralesional injection therapy with OK‐432 was developed as a therapy for operatively difficult lymphangioma (cystic hygroma) and is currently becoming a first‐choice treatment for this disease. The aim of this article was to evaluate the outcome and complications of the treatment of patients with auricular hematoma by OK‐432 therapy.Study Design: Case series with planned data collection.Setting: Yamagata University School of Medicine.Subjects and Methods: We tried this therapy in 21 patients with auricular hematoma between January 2001 and February 2009. We injected OK‐432 solution into the lesion with a 27‐gauge needle to prevent the leak of the agent out of the hematoma. We performed this treatment on an outpatient basis without hospitalization.Results: Disappearance or marked reduction of the lesion were observed in all patients who had this therapy, and local scarring and deformity of the auricle did not occur in any patients. As for side effects, local pain at the injection site and fever (37°C‐38°C) were observed in a few of the patients who had this therapy, but such problems resolved within a few days.Conclusion: These results may allow us to speculate that intralesional injection therapy with OK‐432 is simple, easy, safe, and effective and can be used as a substitute for surgery in the treatment of auricular hematoma.